| 1. |
World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization, 2017.
|
| 2. |
Magiorakos AP, Burns K, Rodríguez Baño J, et al. Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control. Antimicrob Resist Infect Control, 2017, 6: 113.
|
| 3. |
Public Health England. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. London: Public Health England, 2013. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/329227/Acute_trust_toolkit_for_the_early_detection.pdf.
|
| 4. |
Health Protection Scotland. Toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae in Scottish acute settings. (2018-11-20)[2019-01-01]. https://www.hps.scot.nhs.uk/haiic/amr/resourcedetail.aspx?id=478.
|
| 5. |
Centers for Disease Control and Prevention. Facility guidance for control of carbapenem resistant Enterobacteriaceae (CRE): November 2015 update - CRE toolkit 2015. Atlanta: Centers for Disease Control and Prevention, 2015. https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf.
|
| 6. |
Public Health Agency of Canada. Carbapenem resistant Gram-negative bacilli, 2010. (2012-01-26)[2019-01-01]. https://www.health.gov.nl.ca/health/publichealth/cdc/infectioncontrol/carbapenem_resistant_patient.pdf.
|
| 7. |
Australian Commission on Safety and Quality in Health Care. Recommendations for the control of multi-drug resistant Gram-negatives: carbapenem resistant Enterobacteriaceae (October 2013). Sydney: ACSQHC, 2013.
|
| 8. |
French CE, Coope C, Conway L, et al. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review. J Hosp Infect, 2017, 95(1): 3-45.
|
| 9. |
Otter JA, Burgess P, Davies F, et al. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clin Microbiol Infect, 2017, 23(3): 188-196.
|
| 10. |
Feldman N, Adler A, Molshatzki N, et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect, 2013, 19(4): E190-E196.
|
| 11. |
Zimmerman FS, Assous MV, Bdolah-Abram T, et al. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control, 2013, 41(3): 190-194.
|
| 12. |
Schwartz-Neiderman A, Braun T, Fallach N, et al. Risk factors for carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) acquisition among contacts of newly diagnosed CP-CRE patients. Infect Control Hosp Epidemiol, 2016, 37(10): 1219-1225.
|
| 13. |
European Committee on Antimicrobial Susceptibility Testing. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance EUCAST, Växjö. 2013. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisv1.0_20131211.pdf.
|
| 14. |
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Wayne, PA: CLSI2012.
|
